It's hard not to lose patience, when the company couldn't even complete the FDA submission after many assurances. Not sure what the latest snag might be. It is perhaps not so simple and it shows that the company lacks FDA expertise. Meanwhile, the cash position of the company has turned from solid to being shaky and slowly turning towards critical. A sense of urgency is needed, but unfortunately not observed so far.
It's hard not to lose patience, when the company couldn't even...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.5¢ |
Change
-0.025(3.42%) |
Mkt cap ! $159.9M | |||
| Open | High | Low | Value | Volume |
| 73.0¢ | 73.0¢ | 70.0¢ | $45.61K | 63.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 499 | 70.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.0¢ | 14325 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| GSS (ASX) Chart |